Satellos Bioscience Stock Price Patterns

MSCLF Stock  USD 11.25  0.66  5.54%   
As of 7th of February 2026 The value of RSI of Satellos Bioscience's share price is above 80 . This indicates that the otc stock is significantly overbought by investors. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 80

 Buy Stretched

 
Oversold
 
Overbought
Satellos Bioscience stock price prediction is an act of determining the future value of Satellos Bioscience shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Satellos Bioscience's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Satellos Bioscience and does not consider all of the tangible or intangible factors available from Satellos Bioscience's fundamental data. We analyze noise-free headlines and recent hype associated with Satellos Bioscience, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether otc price prediction based on information in financial news can generate trading signals. We use our internally-built news screening methodology to estimate the value of Satellos Bioscience based on different types of headlines from major news networks to social media. Using Satellos Bioscience hype-based prediction, you can estimate the value of Satellos Bioscience from the perspective of Satellos Bioscience response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Satellos Bioscience. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Satellos Bioscience to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Satellos because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Satellos Bioscience after-hype prediction price

    
  USD 11.25  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Satellos Bioscience Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
3.558.4613.37
Details
Naive
Forecast
LowNextHigh
6.1711.0916.00
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.127.5411.95
Details

Satellos Bioscience After-Hype Price Density Analysis

As far as predicting the price of Satellos Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Satellos Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Satellos Bioscience, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Satellos Bioscience Estimiated After-Hype Price Volatility

In the context of predicting Satellos Bioscience's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Satellos Bioscience's historical news coverage. Satellos Bioscience's after-hype downside and upside margins for the prediction period are 6.34 and 16.16, respectively. We have considered Satellos Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
11.25
11.25
After-hype Price
16.16
Upside
Satellos Bioscience is slightly risky at this time. Analysis and calculation of next after-hype price of Satellos Bioscience is based on 3 months time horizon.

Satellos Bioscience OTC Stock Price Outlook Analysis

Have you ever been surprised when a price of a OTC Stock such as Satellos Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Satellos Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Satellos Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.14 
4.91
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
11.25
11.25
0.00 
0.00  
Notes

Satellos Bioscience Hype Timeline

Satellos Bioscience is now traded for 11.25. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Satellos is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is now at 1.14%. %. The volatility of related hype on Satellos Bioscience is about 0.0%, with the expected price after the next announcement by competition of 11.25. About 14.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.1. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Satellos Bioscience recorded a loss per share of 0.47. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 18th of August 2021. Assuming the 90 days horizon the next expected press release will be uncertain.
Check out Satellos Bioscience Basic Forecasting Models to cross-verify your projections.

Satellos Bioscience Related Hype Analysis

Having access to credible news sources related to Satellos Bioscience's direct competition is more important than ever and may enhance your ability to predict Satellos Bioscience's future price movements. Getting to know how Satellos Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Satellos Bioscience may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
IUGNFImugene Limited 0.00 0 per month 6.74 (0) 25.00 (13.64) 47.15 
BSEMBiostem Technologies 0.00 0 per month 6.41  0.09  22.14 (10.97) 48.13 
PBIGFParadigm Biopharmaceuticals Limited 0.00 0 per month 0.00 (0.05) 12.50 (10.00) 37.57 
POLBFPoolbeg Pharma PLC 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
SPHRYStarpharma Holdings 0.00 0 per month 2.76  0.06  7.00 (6.25) 33.24 
VSBCVitaSpring Biomedical Co 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
PRNAFAlterity Therapeutics Limited 0.00 0 per month 0.00  0.08  0.00  0.00  81.61 
HSCHFH Source Holdings 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
KNTPFKintor Pharmaceutical Limited 0.00 0 per month 0.00  0.07  0.00  0.00  27.27 
TOKIFOptima Medical Innovations 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 

Satellos Bioscience Additional Predictive Modules

Most predictive techniques to examine Satellos price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Satellos using various technical indicators. When you analyze Satellos charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Satellos Bioscience Predictive Indicators

The successful prediction of Satellos Bioscience stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Satellos Bioscience, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Satellos Bioscience based on analysis of Satellos Bioscience hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Satellos Bioscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Satellos Bioscience's related companies.

Currently Active Assets on Macroaxis

Complementary Tools for Satellos OTC Stock analysis

When running Satellos Bioscience's price analysis, check to measure Satellos Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Satellos Bioscience is operating at the current time. Most of Satellos Bioscience's value examination focuses on studying past and present price action to predict the probability of Satellos Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Satellos Bioscience's price. Additionally, you may evaluate how the addition of Satellos Bioscience to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world